Related Experiment Video
Updated: Aug 25, 2025

09:48
Monitoring of Nanodrug Accumulation in Murine Breast Cancer Metastases
Published on: August 23, 2024
433
MXenes in Cancer Nanotheranostics.
Siavash Iravani1, Rajender S Varma2
1Faculty of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran.
Nanomaterials (Basel, Switzerland)
|October 14, 2022
Summary
MXenes, versatile 2D materials, show promise for cancer nanotheranostics due to their unique properties. Further research is needed to overcome challenges for clinical translation.
Area of Science:
- Materials Science
- Nanotechnology
- Biomedical Engineering
Background:
- MXenes are 2D materials with exceptional properties like high surface area, conductivity, and tunable surface chemistry.
- These characteristics make them suitable for developing advanced nanostructures.
- MXene-based nanocomposites are emerging as powerful tools in nanomedicine, particularly for cancer theranostics.
Purpose of the Study:
- To review recent advancements in MXene-based nanotheranostics for cancer.
- To highlight the potential of MXenes in cancer diagnosis and therapy.
- To discuss the opportunities and challenges associated with MXene applications in oncology.
Main Methods:
- Exploration of MXene properties relevant to nanotheranostics.
- Investigation of MXene-based micro- and nanocomposites for imaging and therapy.
- Analysis of surface functionalization strategies to enhance performance.
- Review of studies on targeted drug delivery and cancer imaging.
Main Results:
- MXene-based systems offer potential for photoacoustic imaging, photodynamic therapy, and photothermal therapy.
- Functionalized MXenes demonstrate effective targeted anticancer drug delivery and tumor imaging.
- Surface engineering improves biocompatibility, targeting, and biodegradability of MXenes.
- MXenes exhibit auto-fluorescence for tracking and examination.
Conclusions:
- MXenes hold significant promise for multifunctional cancer nanotheranostics.
- Surface modification is key to optimizing MXene performance for biomedical applications.
- Challenges in fabrication, scalability, biocompatibility, and clinical translation require further investigation.

